Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04770194
What this trial is testing

Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SP-8008

Who this might be right for
Acute Coronary SyndromeStroke
Shin Poong Pharmaceutical Co. Ltd. 48
Early research (Phase 1)Study completedNCT01358929
What this trial is testing

RO6807952 in Patients With Diabetes Mellitus Type 2

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 45
Early research (Phase 1)Not Yet RecruitingNCT07230145
What this trial is testing

A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure

Who this might be right for
Heart Failure
Beijing Suncadia Pharmaceuticals Co., Ltd 48
Early research (Phase 1)Enrolling By InvitationNCT07149454
What this trial is testing

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody Injection

Who this might be right for
Tetanus
Lanzhou Institute of Biological Products Co., Ltd 68
Early research (Phase 1)Study completedNCT06037577
What this trial is testing

Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Primary Sclerosing Cholangitis (PSC)Systemic Sclerosis (SSc)
ChemomAb Ltd. 8
Early research (Phase 1)Study completedNCT01863069
What this trial is testing

Avonex®: Safety, Blood Levels and Effects

Who this might be right for
Multiple Sclerosis (MS)
Trio Medicines Ltd. 77
Early research (Phase 1)Study completedNCT01243151
What this trial is testing

Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemia
Pfizer 68
Early research (Phase 1)Study completedNCT01616277
What this trial is testing

Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects

Who this might be right for
Healthy
Pfizer 86
Early research (Phase 1)Looking for participantsNCT07444294
What this trial is testing

A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults

Who this might be right for
Healthy
Scholar Rock, Inc. 76
Early research (Phase 1)Study completedNCT05531097
What this trial is testing

Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C

Who this might be right for
HealthyElevated LDL-C
Haisco Pharmaceutical Group Co., Ltd. 96
Early research (Phase 1)Looking for participantsNCT05995782
What this trial is testing

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

Who this might be right for
Parkinson Disease PsychosisAmyotrophic Lateral Sclerosis (ALS)
1ST Biotherapeutics, Inc. 64
Early research (Phase 1)Study completedNCT02244203
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 56
Early research (Phase 1)UnknownNCT03658070
What this trial is testing

XY0206 in Subjects With Advanced or Metastatic Solid Tumours

Who this might be right for
Advanced or Metastatic Solid Tumours
Shijiazhuang Yiling Pharmaceutical Co. Ltd 34
Early research (Phase 1)Study completedNCT02815839
What this trial is testing

Single Dose Study of SHR4640 in Healthy Subjects

Who this might be right for
Gout; Hyperuricemia
Jiangsu HengRui Medicine Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT03047629
What this trial is testing

Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation

Who this might be right for
Parkinson's DiseaseConstipation
Enterin Inc. 50
Early research (Phase 1)Study completedNCT02396069
What this trial is testing

The Evaluation of Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of JPI-289 in Healthy Male Volunteers

Who this might be right for
Stroke
Jeil Pharmaceutical Co., Ltd. 24
Early research (Phase 1)Study completedNCT03374241
What this trial is testing

A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM15211(Efocipegtrutide)

Who this might be right for
Obesity
Hanmi Pharmaceutical Company Limited 41
Testing effectiveness (Phase 2)Study completedNCT01381094
What this trial is testing

42-Day Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

Who this might be right for
AnemiaKidney Disease
Akebia Therapeutics 93
Early research (Phase 1)Study completedNCT02250222
What this trial is testing

Safety and Tolerability Study of Oral LGD-6972 for Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Ligand Pharmaceuticals 48
Early research (Phase 1)Study completedNCT04052594
What this trial is testing

LY3475766 in Healthy Participants

Who this might be right for
Dyslipidemias
Eli Lilly and Company 48
Next Page